Effect of Ayurvedic Medicine Rohitakdyadi churna and vardhman pippali rasayana liver disease

Comparative Clinical study of Rohitakdya churna ghan vati with Vardhmanpippali rasayan in alcoholic liver disease

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020960

Enrollment

Registered

2019-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K709- Alcoholic liver disease, unspecified

Interventions

Intervention1: Rohitakadya Churna ghan vati: 500mg BD after meal,oral,for 45 days Control Intervention1: Phal Trikadi ghan vati: 500 mg BD after meal,oral,45 days

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients will be randomly selected based on the presence of classical symptoms of Alcoholic liver disease (Hepatitis/ Steato hepatitis). Patients will be subjected to detailed clinical history based on specially prepared Performa. 2)Prior consent will be taken from the patients after explaining the details regarding the treatment. 3.Diagnosed patients of alcohol addiction having classical symptoms of Alcoholic hepatitis/Steatoepatitis such as icterus, Right upper quadrant pain, fever, tachycardia, tender enlarged liver, Anorexia etc with deranged LFT (Liver Function Test) 4.Age between 20 â?? 60 years 5.Either sex

Exclusion criteria

Exclusion criteria: 1.Alcohol addicted patients suffering from liver Cirrhosis complicated by ascites & gastrointestinal bleeding, Mallory-Weiss tears, Wernicke Korsakoffâ??s syndrome (WKS), cerebellar degeneration & all type of Viral Hepatitis. 2.Alcohol addicted patients who are suffering from major psychiatric disorders. 3.Alcohol addicted patients suffering from major systemic illness like diabetes, hypertension, myocardial infarction, ischemic heart disease, pulmonary tuberculosis etc. 4.Patient having Pitta predominant prakriti.

Design outcomes

Primary

Measure	Time frame
1.To find out the clinical efficacy of Rohitakadya Churna Ghana Vati with Vardhaman Pippali Rasayana in Alcoholic Liver Disease. Timepoint: 45 DAYS	—

Secondary

Measure	Time frame
1.To evaluate, elaborate and discussion of Ayurvedic aspect of Alcoholic Liver Disease, withdrawal and management. 2 To study the clinical efficacy of Rohitakadya Churna Ghana Vati with Vardhaman Pippali Rasayana in Alcoholic Liver Disease. 3 To study the clinical efficacy Phalatrikadi Kwath Ghanavati with Vardhaman Pippali Rasayana in Alcoholic Liver Disease. 4 To compare the efficacy of Rohitakadya Churna Ghan Vati with Phalatrikadi kwath Ghana Vati in Alcoholic liver Disease. Timepoint: 45 DAYS	—

Measure

Time frame

1.To evaluate, elaborate and discussion of Ayurvedic aspect of Alcoholic Liver Disease, withdrawal and management. 2 To study the clinical efficacy of Rohitakadya Churna Ghana Vati with Vardhaman Pippali Rasayana in Alcoholic Liver Disease. 3 To study the clinical efficacy Phalatrikadi Kwath Ghanavati with Vardhaman Pippali Rasayana in Alcoholic Liver Disease. 4 To compare the efficacy of Rohitakadya Churna Ghan Vati with Phalatrikadi kwath Ghana Vati in Alcoholic liver Disease. Timepoint: 45 DAYS

—

Countries

India

Contacts

Public Contactanindyalok bandyopadhyay

National Institute of Ayurveda,JAIPUR

anita31sharma@yahoo.com9414078653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026